Post-Bariatric Surgery Complications. Complications of bariatric procedures
Conditions
Interventions
Intervention 1: Intervention group: The patients in the intervention group will receive the Nutrition Bio-Shield (NBS) powder in addition to the standard treatment panel as follows: The daily dose of
Sponsors
Mazandaran University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Body mass index (BMI) above 40 kg/m². Body mass index (BMI) above 35 kg/m² with one or more significant comorbidities (when the individual has been unsuccessful with less invasive weight loss methods or is at high risk of obesity-related complications and mortality).
Exclusion criteria
Exclusion criteria: Patient withdrawal from the study. Recent history of NSAID (Non-Steroidal Anti-Inflammatory Drugs) use (initiated within the past month). Recent history of corticosteroid use (initiated within the past month). Recent history of benzodiazepine use (initiated within the past month) Recent history of calcium channel blocker use (initiated within the past month) Recent history of nitrate use (initiated within the past month) Recent history of alcohol use (initiated within the past month) Recent history of dietary supplement use or need for other supplements during the study (Note: If the patient requires another supplement as prescribed by the physician, they will be excluded from the study) Recent history of beta-2 agonist use (initiated within the past month) Patients who fail to attend follow-up appointments as scheduled Pregnant and breastfeeding mothers Any signs of drug allergies, as diagnosed by the attending physician Worsening of clinical symptoms due to NBS powder consumption, as determined by the attending physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measurement of Micronutrient Levels. Timepoint: Before the intervention, after the completion of the intervention. Method of measurement: Autoanalyzer, ELISA, and Electrochemiluminescence. | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum Levels of Calcium, Phosphorus, and Magnesium. Timepoint: Before the intervention, after the completion of the intervention. Method of measurement: Autoanalyzer.;Levels of Inflammatory Markers such as ESR and CRP. Timepoint: Before the intervention, after the completion of the intervention. Method of measurement: Autoanalyzer and Westergren Method.;Lipid Profile Levels, including Cholesterol, Triglycerides, LDL, and HDL. Timepoint: Autoanalyzer and Westergren Method. Method of measurement: Autoanalyzer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehrdad Mosadegh
Tehran University of Medical Sciences
Outcome results
None listed